ARRIVENT BIOPHARMA INC
AVBPNASDAQ🏆 #2067 by market capUS Equity
$31.26▼ $0.13 (−0.42%)
Live1h▼ 0.2%
24h▼ 0.4%
7d▲ 2.3%
14d▲ 4.1%
30d▼ 7.2%
1y▲ 84.5%
🏦Market Cap
$1.46B
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
57
Weak
📊
Analyst Ratings
Price
$31.26
Total
7
Raised
0
Lowered
0
Avg PT
$45.00
H / L
$45 / $45
| Institution | Action | Rating | Date |
|---|---|---|---|
Truist Securities | Reiterated | Buy | 2026-05-29 |
Citigroup | Reiterated | Buy | 2026-05-13 |
B. Riley Securities | Reiterated | Buy | 2026-03-23 |
Oppenheimer | Reiterated | Outperform | 2026-03-06 |
HC Wainwright & Co. | Reiterated | Buy | 2026-03-06 |
Guggenheim | Reiterated | Buy | 2025-06-24 |
Goldman Sachs | Reiterated | Buy | 2024-09-10 |
One row per institution, most recent rating